- Home
- ACI vs PEN Comparison
ACI vs PEN Comparison
Compare ACI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACI
- PEN
- Stock Information
- Founded
- ACI 1860
- PEN 2004
- Country
- ACI United States
- PEN United States
- Employees
- ACI N/A
- PEN N/A
- Industry
- ACI Food Chains
- PEN Medical/Dental Instruments
- Sector
- ACI Consumer Staples
- PEN Health Care
- Exchange
- ACI Nasdaq
- PEN Nasdaq
- Market Cap
- ACI 12.2B
- PEN 11.1B
- IPO Year
- ACI 2020
- PEN 2015
- Fundamental
- Price
- ACI $21.98
- PEN $267.21
- Analyst Decision
- ACI Buy
- PEN Strong Buy
- Analyst Count
- ACI 12
- PEN 16
- Target Price
- ACI $23.85
- PEN $291.60
- AVG Volume (30 Days)
- ACI 9.0M
- PEN 412.9K
- Earning Date
- ACI 04-15-2025
- PEN 05-06-2025
- Dividend Yield
- ACI 2.73%
- PEN N/A
- EPS Growth
- ACI N/A
- PEN N/A
- EPS
- ACI 1.78
- PEN 0.36
- Revenue
- ACI $79,930,900,000.00
- PEN $1,194,615,000.00
- Revenue This Year
- ACI $2.35
- PEN $14.26
- Revenue Next Year
- ACI $2.44
- PEN $14.29
- P/E Ratio
- ACI $12.34
- PEN $742.64
- Revenue Growth
- ACI 0.97
- PEN 12.86
- 52 Week Low
- ACI $17.00
- PEN $148.00
- 52 Week High
- ACI $22.05
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ACI 60.94
- PEN 43.99
- Support Level
- ACI $20.66
- PEN $273.00
- Resistance Level
- ACI $22.05
- PEN $288.57
- Average True Range (ATR)
- ACI 0.48
- PEN 8.17
- MACD
- ACI 0.02
- PEN -1.26
- Stochastic Oscillator
- ACI 94.96
- PEN 33.31
About ACI Albertsons Companies Inc.
Albertsons is the second largest supermarket operator in the United States with more than 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.